Medicine and Dentistry
Vaccine
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19
100%
Infection
50%
Clinical Study
50%
Development
25%
Patient
25%
Immunization
25%
Neutralizing Antibody
25%
Immunoglobulin A
25%
Lower Respiratory Tract
25%
Upper Respiratory Tract
25%
T-Cell Response
25%
Self-Administration
25%
Coronavirinae
25%
Nasal Vaccine
25%
COVID-19 Vaccine
25%
Nose Mucosa
25%
Pharmacology, Toxicology and Pharmaceutical Science
Vaccine
100%
SARS Coronavirus
100%
Infection
50%
Preclinical Study
50%
Respiratory Tract
25%
Immunoglobulin A
25%
Neutralizing Antibody
25%
Coronavirinae
25%
Immunology and Microbiology
Vaccine Efficacy
100%
Development
16%
T Cell
16%
Immunoglobulin A
16%
Neutralizing Antibody
16%
Upper Respiratory Tract
16%
Lower Respiratory Tract
16%
Environmental Temperature
16%
Coronavirinae
16%
Nose Mucosa
16%